Population Pharmacokinetics of Intravenous Acyclovir in Oncologic Pediatric Patients
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2022.865871
Abstract: Background: Acyclovir represents the first-line prophylaxis and therapy for herpes virus infections. However, its pharmacokinetics in children exposes them to the risk of ineffective or toxic concentrations. The study was aimed at investigating the population… read more here.
Keywords: oncologic pediatric; intravenous acyclovir; pharmacokinetics intravenous; population pharmacokinetics ... See more keywords